Charts on Near Term Uotrends Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts on Near Term Uotrends

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (518)	2/1/2003 8:23:50 AM
From: Sergio H	Read Replies (1) of 1404

Bernard, DFIB broke resistance at 2.50 and now looks good for a run over 3. This past week, DFIB received FDA approval for use of the Powerheart AED on youn children. The press release states that NY is currently the only state to require AEDs in every school with legislation pending in other states. <Cardiac Science President and CEO Raymond W. Cohen said, “The school market is expanding rapidly in both the U.S. and U.K. and we anticipate additional legislation, similar to New York State, which will continue to drive adoption of AEDs in schools. As a result this has become a very important segment for Cardiac Science, a segment in which we are clearly the market leader. We believe that FDA clearance of our new pediatric electrode system, specifically designed and validated for use on smaller patients, will help us to maintain our leadership position in that segment. We will immediately begin to ship these electrode systems, which sell for about $90, to all types of customers who are anxious to deploy the new electrode pads in areas where small children are at risk.”> finance.lycos.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next